GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ustekinumab Fab

Analyse Crystal structure of ustekinumab Fab in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3HMW
Type
protein
Length
432 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ustekinumab Fab light chain; Ustekinumab Fab heavy chain
Ligands
CD
Pockets
4 · best druggability 0.64

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LUstekinumab Fab light chainprotein2147% helix, 52% strand—
HUstekinumab Fab heavy chainprotein2188% helix, 51% strand—

Ligands and binding sites

  • CD · Cadmium ion · metal · 2 copies · chains L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16830.640.7465empty
22020.490.7636empty
3740.340.7617empty
4810.320.7419empty

Interfaces

1 interface between chains.

  • L–H · 1818 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 3HMW · Crystal structure of ustekinumab FAB · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.